Veriheal

APRIL 11, 2022

federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Groff North America is proud to be producing research-grade marijuana, so we can continue growing the field of cannabis-based medicine,” reads an official statement from the company’s website.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

MMJ Recs

MARCH 14, 2024

Qualifying Conditions for Medical Marijuana in West Virginia West Virginia’s medical marijuana program encompasses an extensive list of qualifying conditions, providing access to patients with various chronic or debilitating diseases.

Dispensary 52

Dispensary Programs Legalization Marijuana 52

MMJ Recs

MAY 9, 2024

In this instance, medical cannabis offers a promising alternative or complementary treatment option. As such, we provide you with a comprehensive guide for veterans using medical cannabis and the various aspects of it, including its usage, accessibility, legal considerations, healthcare options, and available resources.

Research and Development 52

Research and Development Therapy Clinical Trials Treatment 52

Cannabis Law Report

JULY 8, 2021

A Swinburne study into the effects on medical cannabis on driving ability has received $358,980 in funding from the federal government’s Road Safety Innovation Fund. The study is the first of its kind and will be conducted within Swinburne’s Drugs and Driving Research unit, which is led by Professor Downey. ‘We Source: [link].

Medicine 98

Medicine Research and Development Safety THC 98

MMJ Recs

NOVEMBER 17, 2023

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. Support for Patient Well-Being The availability of medical marijuana in local communities fosters an environment of support for patients seeking alternative treatments.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

Cannabis Law Report

MAY 29, 2022

Earlier this month, Senators Brian Schatz (D-HI) and Cory Booker (D-NJ) sent a letter to the National Institutes of Health (NIH) and the Food and Drug Administration (FDA) urging both agencies to advance research on the therapeutic effects of psychedelic drugs. [1] Recent Regulatory Developments. Challenges.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

Cannabis Law Report

APRIL 13, 2022

Delic Labs’ latest exemptions enable the Company to develop innovative analytical methods for psychedelic research. Last year, the lab also applied for a Dealer’s License with the intent of commercializing psilocybin research and associated intellectual property (IP) for medical and research purposes.

Research and Development 52

Research and Development Treatment Extraction Medicine 52

MMJ Recs

NOVEMBER 20, 2023

These two cannabinoids represent just a fraction of the compounds within the cannabis plant, and ongoing research continues to uncover the potential of other lesser-known cannabinoids. Additionally, they may help slow the growth of certain types of cancer cells, though further research is needed.

Cannabinoids 98

Cannabinoids Epilepsy Treatment Marijuana 98

MMJ Recs

MARCH 16, 2024

With increasing acceptance of medical marijuana as a legitimate treatment option for various health conditions, the industry has attracted significant attention from investors, entrepreneurs, and policymakers alike. Policy decisions related to taxation, zoning, and advertising also impact the industry’s operations and growth trajectory.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

FEBRUARY 28, 2022

In the past two decades, pioneering research has rekindled interest in the therapeutic use of psychedelic substances such as psilocybin, ibogaine, and dimethyltryptamine (DMT). Indigenous communities have used them for centuries, and researchers studied them in the 1950s and ‘60s. Glenn Cohen & Mason Marks. 20 February 2022.

Research and Development 52

Research and Development Therapy Law Clinical Trials 52

PrestoDoctor

JANUARY 30, 2024

By exploring the signs and symptoms, risk factors, mechanism of action, and treatment options for cannabis-induced psychosis, we can better equip ourselves with the knowledge needed to prevent and manage this condition. Studies have shown that individuals who use cannabis are at an increased risk of developing psychotic symptoms.

Research and Development 52

Research and Development Treatment Conditions Education 52

Cannabis Law Report

DECEMBER 1, 2021

Ethics, Safety, and Abuse in Psychedelic Medicine. As psychedelic medicine becomes more mainstream, we must ensure that all who participate in healing therapeutic sessions, both above ground and in ceremonial or underground therapeutic settings, are safe and accessible to all. Wednesday, December 8th from 12:00-2:00pm PST.

Safety 52

Safety Medicine Therapy Research and Development 52

MMJ Recs

MARCH 20, 2024

Many dispensaries also offer additional services such as educational resources, patient consultations, and ongoing support programs to address patient concerns and enhance their overall treatment experience. These expansions aim to increase patient access and address supply shortages experienced in the past.

Dispensary 52

Dispensary Programs Access Patients 52

Veriheal

SEPTEMBER 23, 2021

Note: Veriheal does not support illegally consuming therapeutic substances such as Iboga but acknowledges that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. Is There Any Research on Iboga and Its Medicinal Properties?

Treatment 98

Treatment Medicine Research and Development Therapy 98

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JULY 19, 2021

We don’t want to see research fall to the wayside as it has for cannabis, both in Canada and globally. We are in a mental health crisis and its critical to ensure that we conduct clinical trials to demonstrate safety, and efficacy up to and including phase 3 large scale clinical trials.

Clinical Trials 98

Clinical Trials Research and Development Hybrid Medicine 98

Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. MMJ International Holdings is developing oral drug products from natural whole plant extract derivatives from the marijuana plant containing THC and CBD. Orphan Drug Designation?

DEA 66

DEA Clinical Trials THC Research and Development 66

Cannabis Law Report

DECEMBER 7, 2021

Despite the increased use of medical cannabinoids, the efficacy and safety of the treatment among children remain uncertain. The objective was to study the efficacy and safety of medical cannabinoids in children. Adverse mental events were reported as well, however, more research should be performed to assess well this outcome.

Safety 52

Safety Cannabinoids Events Data 52

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

AUGUST 27, 2021

The Board will advise Delic and its subsidiaries, including Ketamine Infusion Centers, Delic Labs and others, as they develop safety protocols and best practices pertaining to legal psychedelic wellness treatments today and those legalized in the future. About Delic Corp, Inc.

Research and Development 98

Research and Development Treatment Media Medicine 98

Cannabis Law Report

JANUARY 12, 2022

Through this collaboration, the NPA and Maya will offer both the education and the technology infrastructure needed to make this possible, ensuring accessibility and safety to all communities. “We The Maya platform empowers psychedelic researchers, providers, and participants to collectively chart psychedelic best practices.

Research and Development 52

Research and Development Therapy Safety Clinical Trials 52

Veriheal

JUNE 30, 2023

A study investigated psilocybin’s effect on alcohol addiction, the FDA outlined best practices for future psychedelic research, and the NCAA is inching toward cannabis policy change. For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial.

Clinical Trials 98

Clinical Trials Research and Development Therapy Policy 98

Cannabis Law Report

JULY 24, 2021

At Mydecine, we are excited to expand our drug development program to include the improvement of entactogenic compounds,” said Rob Roscow, Chief Scientific Officer. The company is scaling its proprietary research and development methods in order to become one of the first to produce and bring to market psilocybin-based treatments.

Research and Development 105

Research and Development Clinical Trials Therapy Events 105

MMJ Recs

FEBRUARY 21, 2024

Through an examination of existing research and anecdotal evidence, we aim to provide a closer look at the potential effects of medical marijuana on women’s health. Research suggests that cannabinoids may have anti-inflammatory and analgesic effects, potentially aiding in symptom relief.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

The Cannigma

JUNE 2, 2023

The government remains steadfast in its commitment to maintaining strict drug laws to ensure public safety. The use of cannabis for medicinal purposes is not permitted, and there are no legal avenues for patients to access cannabis-based medications. Is weed legal in Singapore? No, weed is illegal in Singapore.

Law 52

Law Research and Development Consumption Therapy 52

Medicinal Genomics

JANUARY 10, 2024

CannMed started in 2016, when Medicinal Genomics partnered with Dr. Raphael Mechoulam to host the leading researchers and clinicians in cannabinoid medicine at Boston’s Harvard Medical School. Look no further than the CannMed Advisory Board for evidence that the most esteemed clinicians and researchers make the trip to CannMed each year.

Research and Development 52

Research and Development Events Education Medicine 52

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. While psychedelic therapies make their way through the drug development pipeline, seven U.S.

Law 59

Law Policy Research and Development Clinical Trials 59

The Cannigma

JANUARY 21, 2021

It is often called “the mother of all cannabinoids,” and it holds potential as a treatment for conditions such as diabetes, ALS, and Huntington’s disease, although human studies are seriously lacking. And unlike THC and CBD, there’s practically no scientific information about the safety or dosing of CBG-dominant products.

Research and Development 145

Research and Development Blood Pressure Conditions Cannabinoids 145

Veriheal

JANUARY 15, 2024

Active research was carried out on the effects of these drug policies on society and the results, in these reports, have led the United Nations to consider a favorable revision of drug policies in order to protect human rights. 2023 World UN World Drug Report The 2023 World Drug Report urges the development of effective drug policies.

Policy 117

Policy Research and Development Collective Law 117

Cannabis Law Report

JUNE 5, 2019

The Pharmaceutical Organization, Department of Medical Affairs, signed a joint research on standard quality medical marijuana extracts for patients with chemo-allergic cancer, epilepsy, muscle contraction in patients with deteriorating nerve sheaths. Effective, most effective in treatment Relieve symptoms. Today (30 May) at 09.30

Pharmaceutical 40

Pharmaceutical Extraction Epilepsy Research and Development 40

Veriheal

JULY 23, 2020

According to the Oregon Cannabis Association (OCA) , police budgets received more than $2 million directly from cannabis tax proceeds last year – despite the city passing a measure in 2016 stipulating that those funds should be designated for substance misuse treatment, public safety, and small business development.

Research and Development 98

Research and Development Safety Treatment Cannabis 98

Veriheal

AUGUST 7, 2022

New data published in the Journal of Cannabis Research claims that almost one in two authorized medical cannabis patients in Canada managed to either completely stop or reduce their intake of controlled substances, such as alcohol and opioids , by using cannabis. Cannabis’ Place in Substance Abuse Recovery .

Consumption 109

Consumption Patients Research and Development Data 109

The Cannigma

FEBRUARY 2, 2021

In light of these results, the researchers behind the survey say that physicians should pay special consideration to these aspects when advising patients on their medical cannabis treatment options. Patients can also access CBD products without a prescription through local pharmacies. Parkinson’s disease and cannabis.

Patients 87

Patients Clinical Trials Research and Development Treatment 87

Veriheal

JANUARY 18, 2024

In a revolutionary development that reflects the ever-changing healthcare arena, cannabis nursing has earned official recognition as a specialized field in nursing. They position cannabis as a legitimate and valuable treatment option within the broader medical community. They strive to create an accepting and understanding environment.

Education 113

Education Therapy Patients Research and Development 113

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Over the prior three years or so, 41,260 RYAH-connected patients reported medical cannabis use for the treatment of pain. RYAH Group Inc. The Upshot.

Data 105

Data Clinical Trials Research and Development Indica 105

Cannabis Law Report

AUGUST 12, 2021

Highlights: Phase IIb COMP360 psilocybin therapy trial for treatment-resistant depression (TRD) close to completion; on track to report data by end of 2021. Partnership being developed with leading UK institutions to accelerate psychedelic research and develop new models of mental health care in the UK. million, or $0.79

Clinical Trials 98

Clinical Trials Therapy Research and Development Data 98

Veriheal

AUGUST 24, 2022

If passed, the Department of Regulatory Agencies would be required to develop rules that would allow for therapeutic psychedelic programs at licensed healing centers for adults to receive psychedelic treatments by a trained facilitator. Research and Testimonials Point to Psychedelics’ Therapeutic Benefits.

Legalization 108

Legalization Medicine Decriminalization Research and Development 108